 SAN FRANCISCO and SAN DIEGO, June 01, 2022 GLOBE NEWSWIRE -- Kinnate Biopharma Inc. Nasdaq: KNTE Kinnate, a clinical-stage precision oncology company, today announced that the company will participate in two upcoming in-person investor conferences: 